instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19 pneumonia'. | A 34-Year-Old Woman from Brazil with Pulmonary Lymphangioleiomyomatosis Diagnosed by Raised Serum Vascular Endothelial Growth Factor-D (VEGF-D) Levels and Lung Cysts on Computed Tomography Imaging Presenting with COVID-19 Pneumonia.
BACKGROUND There is growing concern about the clinical course of certain diseases in pa... | CEFEPIME HYDROCHLORIDE, SIROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34330886 | 19,932,485 | 2021-07-31 |
What was the outcome of reaction 'COVID-19 pneumonia'? | A 34-Year-Old Woman from Brazil with Pulmonary Lymphangioleiomyomatosis Diagnosed by Raised Serum Vascular Endothelial Growth Factor-D (VEGF-D) Levels and Lung Cysts on Computed Tomography Imaging Presenting with COVID-19 Pneumonia.
BACKGROUND There is growing concern about the clinical course of certain diseases in pa... | Recovering | ReactionOutcome | CC BY-NC-ND | 34330886 | 19,932,485 | 2021-07-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bradycardia'. | Hemadsorption as rescue therapy for patients with multisystem organ failure in pediatric intensive care-Report of two cases reports and review of the literature.
Hemadsorption via the cytokine-adsorber CytoSorb (CytoSorbents Europe, Berlin, Germany) has successfully been used as an adjunctive method in adults, mainly f... | EPINEPHRINE, NOREPINEPHRINE | DrugsGivenReaction | CC BY-NC | 34331775 | 20,330,437 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Hemadsorption as rescue therapy for patients with multisystem organ failure in pediatric intensive care-Report of two cases reports and review of the literature.
Hemadsorption via the cytokine-adsorber CytoSorb (CytoSorbents Europe, Berlin, Germany) has successfully been used as an adjunctive method in adults, mainly f... | CIPROFLOXACIN, FLUCONAZOLE, GENTAMICIN, HUMAN IMMUNOGLOBULIN G, HUMAN PLASMA, LINEZOLID, MEROPENEM, PENTOXIFYLLINE, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 34331775 | 20,326,889 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Hemadsorption as rescue therapy for patients with multisystem organ failure in pediatric intensive care-Report of two cases reports and review of the literature.
Hemadsorption via the cytokine-adsorber CytoSorb (CytoSorbents Europe, Berlin, Germany) has successfully been used as an adjunctive method in adults, mainly f... | CEFUROXIME, CIPROFLOXACIN, FLUCONAZOLE, GENTAMICIN, HUMAN IMMUNOGLOBULIN G, LINEZOLID, MEROPENEM, PENTOXIFYLLINE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34331775 | 20,329,882 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Generalised oedema'. | Hemadsorption as rescue therapy for patients with multisystem organ failure in pediatric intensive care-Report of two cases reports and review of the literature.
Hemadsorption via the cytokine-adsorber CytoSorb (CytoSorbents Europe, Berlin, Germany) has successfully been used as an adjunctive method in adults, mainly f... | CIPROFLOXACIN, FLUCONAZOLE, GENTAMICIN, HUMAN IMMUNOGLOBULIN G, HUMAN PLASMA, LINEZOLID, MEROPENEM, PENTOXIFYLLINE, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 34331775 | 20,326,889 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypotension'. | Hemadsorption as rescue therapy for patients with multisystem organ failure in pediatric intensive care-Report of two cases reports and review of the literature.
Hemadsorption via the cytokine-adsorber CytoSorb (CytoSorbents Europe, Berlin, Germany) has successfully been used as an adjunctive method in adults, mainly f... | EPINEPHRINE, NOREPINEPHRINE | DrugsGivenReaction | CC BY-NC | 34331775 | 20,330,437 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Hemadsorption as rescue therapy for patients with multisystem organ failure in pediatric intensive care-Report of two cases reports and review of the literature.
Hemadsorption via the cytokine-adsorber CytoSorb (CytoSorbents Europe, Berlin, Germany) has successfully been used as an adjunctive method in adults, mainly f... | FILGRASTIM, HUMAN PLASMA, HUMAN PLATELET, ALLOGENIC, HUMAN RED BLOOD CELL | DrugsGivenReaction | CC BY-NC | 34331775 | 20,165,170 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | Hemadsorption as rescue therapy for patients with multisystem organ failure in pediatric intensive care-Report of two cases reports and review of the literature.
Hemadsorption via the cytokine-adsorber CytoSorb (CytoSorbents Europe, Berlin, Germany) has successfully been used as an adjunctive method in adults, mainly f... | CIPROFLOXACIN, FLUCONAZOLE, GENTAMICIN, HUMAN IMMUNOGLOBULIN G, HUMAN PLASMA, LINEZOLID, MEROPENEM, PENTOXIFYLLINE, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 34331775 | 20,326,889 | 2021-12 |
What was the outcome of reaction 'Acute kidney injury'? | Hemadsorption as rescue therapy for patients with multisystem organ failure in pediatric intensive care-Report of two cases reports and review of the literature.
Hemadsorption via the cytokine-adsorber CytoSorb (CytoSorbents Europe, Berlin, Germany) has successfully been used as an adjunctive method in adults, mainly f... | Recovering | ReactionOutcome | CC BY-NC | 34331775 | 20,330,437 | 2021-12 |
What was the outcome of reaction 'Bradycardia'? | Hemadsorption as rescue therapy for patients with multisystem organ failure in pediatric intensive care-Report of two cases reports and review of the literature.
Hemadsorption via the cytokine-adsorber CytoSorb (CytoSorbents Europe, Berlin, Germany) has successfully been used as an adjunctive method in adults, mainly f... | Recovered | ReactionOutcome | CC BY-NC | 34331775 | 20,330,437 | 2021-12 |
What was the outcome of reaction 'Haemodynamic instability'? | Hemadsorption as rescue therapy for patients with multisystem organ failure in pediatric intensive care-Report of two cases reports and review of the literature.
Hemadsorption via the cytokine-adsorber CytoSorb (CytoSorbents Europe, Berlin, Germany) has successfully been used as an adjunctive method in adults, mainly f... | Recovering | ReactionOutcome | CC BY-NC | 34331775 | 20,329,882 | 2021-12 |
What was the outcome of reaction 'Hypotension'? | Hemadsorption as rescue therapy for patients with multisystem organ failure in pediatric intensive care-Report of two cases reports and review of the literature.
Hemadsorption via the cytokine-adsorber CytoSorb (CytoSorbents Europe, Berlin, Germany) has successfully been used as an adjunctive method in adults, mainly f... | Recovered | ReactionOutcome | CC BY-NC | 34331775 | 20,330,437 | 2021-12 |
What was the outcome of reaction 'Respiratory failure'? | Hemadsorption as rescue therapy for patients with multisystem organ failure in pediatric intensive care-Report of two cases reports and review of the literature.
Hemadsorption via the cytokine-adsorber CytoSorb (CytoSorbents Europe, Berlin, Germany) has successfully been used as an adjunctive method in adults, mainly f... | Recovered | ReactionOutcome | CC BY-NC | 34331775 | 20,165,170 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Adult-Onset Autoimmune Enteropathy in an European Tertiary Referral Center.
Adult-onset autoimmune enteropathy (AIE) is a rare cause of severe chronic diarrhea because of small intestinal villous atrophy. We report on patients with adult-onset AIE in an European referral center.
Retrospective study including patient... | CLADRIBINE, CYCLOSPORINE, PREDNISOLONE, THIOGUANINE ANHYDROUS | DrugsGivenReaction | CC BY-NC-ND | 34333499 | 20,998,114 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Adult-Onset Autoimmune Enteropathy in an European Tertiary Referral Center.
Adult-onset autoimmune enteropathy (AIE) is a rare cause of severe chronic diarrhea because of small intestinal villous atrophy. We report on patients with adult-onset AIE in an European referral center.
Retrospective study including patient... | CLADRIBINE, CYCLOSPORINE, PREDNISOLONE, THIOGUANINE ANHYDROUS | DrugsGivenReaction | CC BY-NC-ND | 34333499 | 20,998,114 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acne'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Alopecia'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anal abscess'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angiopathy'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug eruption'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enteritis infectious'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gait disturbance'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic function abnormal'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Herpes zoster'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Interstitial lung disease'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Jugular vein thrombosis'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Listeria sepsis'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malaise'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Melaena'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nasopharyngitis'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ocular hyperaemia'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pain in extremity'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia bacterial'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia legionella'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Shock'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect decreased'. | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | AZATHIOPRINE, GOLIMUMAB, MERCAPTOPURINE | DrugsGivenReaction | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
What was the administration route of drug 'GOLIMUMAB'? | Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance.
Golimumab (GLM) is an anti-tumor necrosis factor-α drug approved for treating moderate-to-severe active ulcerative colitis (UC). A 52-week post-marketing surveillance (PMS) was initiate... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 34333910 | 19,693,534 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Altered state of consciousness'. | Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital.
BACKGROUND
Although the over-the-counter H1 receptor antagonist diphenhydramine is not a common drug of abuse, it was recently recognized as one of the substances causing acute poi... | DIPHENHYDRAMINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34334133 | 19,854,410 | 2021-08-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Communication disorder'. | Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital.
BACKGROUND
Although the over-the-counter H1 receptor antagonist diphenhydramine is not a common drug of abuse, it was recently recognized as one of the substances causing acute poi... | DIPHENHYDRAMINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34334133 | 19,854,423 | 2021-08-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depressed level of consciousness'. | Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital.
BACKGROUND
Although the over-the-counter H1 receptor antagonist diphenhydramine is not a common drug of abuse, it was recently recognized as one of the substances causing acute poi... | UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 34334133 | 19,816,096 | 2021-08-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional overdose'. | Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital.
BACKGROUND
Although the over-the-counter H1 receptor antagonist diphenhydramine is not a common drug of abuse, it was recently recognized as one of the substances causing acute poi... | DIPHENHYDRAMINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34334133 | 19,854,423 | 2021-08-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Restlessness'. | Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital.
BACKGROUND
Although the over-the-counter H1 receptor antagonist diphenhydramine is not a common drug of abuse, it was recently recognized as one of the substances causing acute poi... | DIPHENHYDRAMINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34334133 | 19,854,423 | 2021-08-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Suicide attempt'. | Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital.
BACKGROUND
Although the over-the-counter H1 receptor antagonist diphenhydramine is not a common drug of abuse, it was recently recognized as one of the substances causing acute poi... | DIPHENHYDRAMINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34334133 | 19,854,410 | 2021-08-02 |
What was the administration route of drug 'DIPHENHYDRAMINE HYDROCHLORIDE'? | Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital.
BACKGROUND
Although the over-the-counter H1 receptor antagonist diphenhydramine is not a common drug of abuse, it was recently recognized as one of the substances causing acute poi... | Oral | DrugAdministrationRoute | CC BY | 34334133 | 19,854,410 | 2021-08-02 |
What was the administration route of drug 'UNSPECIFIED INGREDIENT'? | Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital.
BACKGROUND
Although the over-the-counter H1 receptor antagonist diphenhydramine is not a common drug of abuse, it was recently recognized as one of the substances causing acute poi... | Oral | DrugAdministrationRoute | CC BY | 34334133 | 19,816,096 | 2021-08-02 |
What was the outcome of reaction 'Altered state of consciousness'? | Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital.
BACKGROUND
Although the over-the-counter H1 receptor antagonist diphenhydramine is not a common drug of abuse, it was recently recognized as one of the substances causing acute poi... | Recovered | ReactionOutcome | CC BY | 34334133 | 19,854,410 | 2021-08-02 |
What was the outcome of reaction 'Communication disorder'? | Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital.
BACKGROUND
Although the over-the-counter H1 receptor antagonist diphenhydramine is not a common drug of abuse, it was recently recognized as one of the substances causing acute poi... | Recovered | ReactionOutcome | CC BY | 34334133 | 19,854,423 | 2021-08-02 |
What was the outcome of reaction 'Depressed level of consciousness'? | Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital.
BACKGROUND
Although the over-the-counter H1 receptor antagonist diphenhydramine is not a common drug of abuse, it was recently recognized as one of the substances causing acute poi... | Recovered | ReactionOutcome | CC BY | 34334133 | 19,816,096 | 2021-08-02 |
What was the outcome of reaction 'Overdose'? | Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital.
BACKGROUND
Although the over-the-counter H1 receptor antagonist diphenhydramine is not a common drug of abuse, it was recently recognized as one of the substances causing acute poi... | Recovered | ReactionOutcome | CC BY | 34334133 | 19,816,096 | 2021-08-02 |
What was the outcome of reaction 'Restlessness'? | Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital.
BACKGROUND
Although the over-the-counter H1 receptor antagonist diphenhydramine is not a common drug of abuse, it was recently recognized as one of the substances causing acute poi... | Recovered | ReactionOutcome | CC BY | 34334133 | 19,854,423 | 2021-08-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Progressive Cytopenia Developing during Treatment of Cryptococcosis in a Patient with HIV Infection and Bone Marrow Cryptococcal Infection.
Cytopenia is a common complication in patients with human immunodeficiency virus (HIV) infection. Identifying the cause is demanding because of the wide range of possible diagnoses... | AMPHOTERICIN B, FLUCONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34334563 | 20,481,796 | 2021-07-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Progressive Cytopenia Developing during Treatment of Cryptococcosis in a Patient with HIV Infection and Bone Marrow Cryptococcal Infection.
Cytopenia is a common complication in patients with human immunodeficiency virus (HIV) infection. Identifying the cause is demanding because of the wide range of possible diagnoses... | AMPHOTERICIN B, FLUCONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34334563 | 20,481,796 | 2021-07-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancytopenia'. | Progressive Cytopenia Developing during Treatment of Cryptococcosis in a Patient with HIV Infection and Bone Marrow Cryptococcal Infection.
Cytopenia is a common complication in patients with human immunodeficiency virus (HIV) infection. Identifying the cause is demanding because of the wide range of possible diagnoses... | AMPHOTERICIN B, FLUCONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34334563 | 20,481,796 | 2021-07-30 |
What was the dosage of drug 'AMPHOTERICIN B'? | Progressive Cytopenia Developing during Treatment of Cryptococcosis in a Patient with HIV Infection and Bone Marrow Cryptococcal Infection.
Cytopenia is a common complication in patients with human immunodeficiency virus (HIV) infection. Identifying the cause is demanding because of the wide range of possible diagnoses... | 3.3 MG/KG, DAILY | DrugDosageText | CC BY-NC-ND | 34334563 | 20,481,796 | 2021-07-30 |
What was the outcome of reaction 'Pancytopenia'? | Progressive Cytopenia Developing during Treatment of Cryptococcosis in a Patient with HIV Infection and Bone Marrow Cryptococcal Infection.
Cytopenia is a common complication in patients with human immunodeficiency virus (HIV) infection. Identifying the cause is demanding because of the wide range of possible diagnoses... | Recovered | ReactionOutcome | CC BY-NC-ND | 34334563 | 20,481,796 | 2021-07-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Clinical and Serological Features and Pregnancy Outcomes in Women with Polymyositis/Dermatomyositis: A Case-based Review.
We encountered a 30-year-old woman who developed dermatomyositis during pregnancy and was positive for anti-Mi-2 antibodies. She was successfully treated with prednisolone and tacrolimus and deliver... | PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34334572 | 19,694,328 | 2021-07-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Clinical and Serological Features and Pregnancy Outcomes in Women with Polymyositis/Dermatomyositis: A Case-based Review.
We encountered a 30-year-old woman who developed dermatomyositis during pregnancy and was positive for anti-Mi-2 antibodies. She was successfully treated with prednisolone and tacrolimus and deliver... | PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34334572 | 19,694,328 | 2021-07-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature delivery'. | Clinical and Serological Features and Pregnancy Outcomes in Women with Polymyositis/Dermatomyositis: A Case-based Review.
We encountered a 30-year-old woman who developed dermatomyositis during pregnancy and was positive for anti-Mi-2 antibodies. She was successfully treated with prednisolone and tacrolimus and deliver... | PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34334572 | 19,694,328 | 2021-07-30 |
What is the weight of the patient? | Clinical and Serological Features and Pregnancy Outcomes in Women with Polymyositis/Dermatomyositis: A Case-based Review.
We encountered a 30-year-old woman who developed dermatomyositis during pregnancy and was positive for anti-Mi-2 antibodies. She was successfully treated with prednisolone and tacrolimus and deliver... | 50 kg. | Weight | CC BY-NC-ND | 34334572 | 19,694,328 | 2021-07-30 |
What was the dosage of drug 'TACROLIMUS'? | Clinical and Serological Features and Pregnancy Outcomes in Women with Polymyositis/Dermatomyositis: A Case-based Review.
We encountered a 30-year-old woman who developed dermatomyositis during pregnancy and was positive for anti-Mi-2 antibodies. She was successfully treated with prednisolone and tacrolimus and deliver... | 3 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34334572 | 19,694,328 | 2021-07-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Serious Complications After Epidural Catheter Placement: Two Case Reports.
Thoracic epidural analgesia (TEA) is a standard procedure in multimodal analgesia applied in major thoracic and abdominal surgeries. Two cases are presented with serious complications related to TEA. In both cases, earlier reaction of the treati... | DABIGATRAN, ENOXAPARIN SODIUM, ROPIVACAINE HYDROCHLORIDE, SUFENTANIL, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 34335056 | 19,727,384 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Extradural haematoma'. | Serious Complications After Epidural Catheter Placement: Two Case Reports.
Thoracic epidural analgesia (TEA) is a standard procedure in multimodal analgesia applied in major thoracic and abdominal surgeries. Two cases are presented with serious complications related to TEA. In both cases, earlier reaction of the treati... | DABIGATRAN, ENOXAPARIN SODIUM, ROPIVACAINE HYDROCHLORIDE, SUFENTANIL, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 34335056 | 19,727,384 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoaesthesia'. | Serious Complications After Epidural Catheter Placement: Two Case Reports.
Thoracic epidural analgesia (TEA) is a standard procedure in multimodal analgesia applied in major thoracic and abdominal surgeries. Two cases are presented with serious complications related to TEA. In both cases, earlier reaction of the treati... | DABIGATRAN, ENOXAPARIN SODIUM, ROPIVACAINE HYDROCHLORIDE, SUFENTANIL, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 34335056 | 19,727,384 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paraplegia'. | Serious Complications After Epidural Catheter Placement: Two Case Reports.
Thoracic epidural analgesia (TEA) is a standard procedure in multimodal analgesia applied in major thoracic and abdominal surgeries. Two cases are presented with serious complications related to TEA. In both cases, earlier reaction of the treati... | DABIGATRAN, ENOXAPARIN SODIUM, ROPIVACAINE HYDROCHLORIDE, SUFENTANIL, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 34335056 | 19,727,384 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Serious Complications After Epidural Catheter Placement: Two Case Reports.
Thoracic epidural analgesia (TEA) is a standard procedure in multimodal analgesia applied in major thoracic and abdominal surgeries. Two cases are presented with serious complications related to TEA. In both cases, earlier reaction of the treati... | DABIGATRAN, ENOXAPARIN SODIUM, ROPIVACAINE HYDROCHLORIDE, SUFENTANIL, VANCOMYCIN | DrugsGivenReaction | CC BY-NC | 34335056 | 19,727,384 | 2021 |
What is the weight of the patient? | Serious Complications After Epidural Catheter Placement: Two Case Reports.
Thoracic epidural analgesia (TEA) is a standard procedure in multimodal analgesia applied in major thoracic and abdominal surgeries. Two cases are presented with serious complications related to TEA. In both cases, earlier reaction of the treati... | 100 kg. | Weight | CC BY-NC | 34335056 | 19,727,384 | 2021 |
What was the administration route of drug 'ENOXAPARIN SODIUM'? | Serious Complications After Epidural Catheter Placement: Two Case Reports.
Thoracic epidural analgesia (TEA) is a standard procedure in multimodal analgesia applied in major thoracic and abdominal surgeries. Two cases are presented with serious complications related to TEA. In both cases, earlier reaction of the treati... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 34335056 | 19,727,384 | 2021 |
What was the administration route of drug 'VANCOMYCIN'? | Serious Complications After Epidural Catheter Placement: Two Case Reports.
Thoracic epidural analgesia (TEA) is a standard procedure in multimodal analgesia applied in major thoracic and abdominal surgeries. Two cases are presented with serious complications related to TEA. In both cases, earlier reaction of the treati... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34335056 | 19,727,384 | 2021 |
What was the outcome of reaction 'Paraplegia'? | Serious Complications After Epidural Catheter Placement: Two Case Reports.
Thoracic epidural analgesia (TEA) is a standard procedure in multimodal analgesia applied in major thoracic and abdominal surgeries. Two cases are presented with serious complications related to TEA. In both cases, earlier reaction of the treati... | Not recovered | ReactionOutcome | CC BY-NC | 34335056 | 19,727,384 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report.
Aneurysmal bone cysts (ABCs) are rare benign pseudotumoral bone lesions with potential aggressive behavior due to the extensive destruction of surrounding bone. Traditionally, these tumors were treated wi... | DENOSUMAB | DrugsGivenReaction | CC BY | 34335473 | 19,724,333 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dehydration'. | Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report.
Aneurysmal bone cysts (ABCs) are rare benign pseudotumoral bone lesions with potential aggressive behavior due to the extensive destruction of surrounding bone. Traditionally, these tumors were treated wi... | DENOSUMAB | DrugsGivenReaction | CC BY | 34335473 | 19,724,333 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Growth disorder'. | Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report.
Aneurysmal bone cysts (ABCs) are rare benign pseudotumoral bone lesions with potential aggressive behavior due to the extensive destruction of surrounding bone. Traditionally, these tumors were treated wi... | DENOSUMAB | DrugsGivenReaction | CC BY | 34335473 | 19,724,333 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypercalcaemia'. | Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report.
Aneurysmal bone cysts (ABCs) are rare benign pseudotumoral bone lesions with potential aggressive behavior due to the extensive destruction of surrounding bone. Traditionally, these tumors were treated wi... | DENOSUMAB | DrugsGivenReaction | CC BY | 34335473 | 19,724,333 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertensive crisis'. | Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report.
Aneurysmal bone cysts (ABCs) are rare benign pseudotumoral bone lesions with potential aggressive behavior due to the extensive destruction of surrounding bone. Traditionally, these tumors were treated wi... | DENOSUMAB | DrugsGivenReaction | CC BY | 34335473 | 19,724,333 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Knee deformity'. | Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report.
Aneurysmal bone cysts (ABCs) are rare benign pseudotumoral bone lesions with potential aggressive behavior due to the extensive destruction of surrounding bone. Traditionally, these tumors were treated wi... | DENOSUMAB | DrugsGivenReaction | CC BY | 34335473 | 19,724,333 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm progression'. | Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report.
Aneurysmal bone cysts (ABCs) are rare benign pseudotumoral bone lesions with potential aggressive behavior due to the extensive destruction of surrounding bone. Traditionally, these tumors were treated wi... | DENOSUMAB | DrugsGivenReaction | CC BY | 34335473 | 19,724,333 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report.
Aneurysmal bone cysts (ABCs) are rare benign pseudotumoral bone lesions with potential aggressive behavior due to the extensive destruction of surrounding bone. Traditionally, these tumors were treated wi... | DENOSUMAB | DrugsGivenReaction | CC BY | 34335473 | 19,724,333 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteosclerosis'. | Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report.
Aneurysmal bone cysts (ABCs) are rare benign pseudotumoral bone lesions with potential aggressive behavior due to the extensive destruction of surrounding bone. Traditionally, these tumors were treated wi... | DENOSUMAB | DrugsGivenReaction | CC BY | 34335473 | 19,724,333 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rebound effect'. | Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report.
Aneurysmal bone cysts (ABCs) are rare benign pseudotumoral bone lesions with potential aggressive behavior due to the extensive destruction of surrounding bone. Traditionally, these tumors were treated wi... | DENOSUMAB | DrugsGivenReaction | CC BY | 34335473 | 19,724,333 | 2021 |
What was the administration route of drug 'DENOSUMAB'? | Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case Report.
Aneurysmal bone cysts (ABCs) are rare benign pseudotumoral bone lesions with potential aggressive behavior due to the extensive destruction of surrounding bone. Traditionally, these tumors were treated wi... | Subcutaneous | DrugAdministrationRoute | CC BY | 34335473 | 19,724,333 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia.
In the absence of a European standardized postmarketing food supplement surveillance system (nutrivigilance), some member states and companies have developed their own approaches to monitoring pot... | ROSUVASTATIN CALCIUM, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-SA | 34336013 | 19,786,276 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rhabdomyolysis'. | Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia.
In the absence of a European standardized postmarketing food supplement surveillance system (nutrivigilance), some member states and companies have developed their own approaches to monitoring pot... | ROSUVASTATIN CALCIUM, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-SA | 34336013 | 19,786,276 | 2021 |
What was the outcome of reaction 'Rhabdomyolysis'? | Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia.
In the absence of a European standardized postmarketing food supplement surveillance system (nutrivigilance), some member states and companies have developed their own approaches to monitoring pot... | Recovered | ReactionOutcome | CC BY-NC-SA | 34336013 | 19,786,276 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Invasive sinus aspergillosis with mycotic aneurysm of the vertebral artery and subarachnoid hemorrhage - Case report.
Invasive sinus aspergillosis is a rare life-threatening condition usually found in immunocompromised patients. The fungus spreads from paranasal sinuses into the central nervous system by direct extensi... | CEFEPIME HYDROCHLORIDE, DEXAMETHASONE, METRONIDAZOLE, VORICONAZOLE | DrugsGivenReaction | CC BY | 34336072 | 19,831,708 | 2021-09 |
What was the outcome of reaction 'Disease progression'? | Invasive sinus aspergillosis with mycotic aneurysm of the vertebral artery and subarachnoid hemorrhage - Case report.
Invasive sinus aspergillosis is a rare life-threatening condition usually found in immunocompromised patients. The fungus spreads from paranasal sinuses into the central nervous system by direct extensi... | Fatal | ReactionOutcome | CC BY | 34336072 | 19,831,708 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood parathyroid hormone increased'. | Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis - Case report.
Hypercalcaemia is most commonly a sign of primary hyperparathyroidism but can also be a sign of an active granulomatous disease. Standard treatment for primary hyperparathyroidism caused by a solitary parat... | CHOLECALCIFEROL, DENOSUMAB | DrugsGivenReaction | CC BY | 34336200 | 19,937,509 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypercalcaemia'. | Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis - Case report.
Hypercalcaemia is most commonly a sign of primary hyperparathyroidism but can also be a sign of an active granulomatous disease. Standard treatment for primary hyperparathyroidism caused by a solitary parat... | CHOLECALCIFEROL, DENOSUMAB | DrugsGivenReaction | CC BY | 34336200 | 19,937,509 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis - Case report.
Hypercalcaemia is most commonly a sign of primary hyperparathyroidism but can also be a sign of an active granulomatous disease. Standard treatment for primary hyperparathyroidism caused by a solitary parat... | CHOLECALCIFEROL, DENOSUMAB | DrugsGivenReaction | CC BY | 34336200 | 19,937,509 | 2021-08 |
What was the dosage of drug 'CHOLECALCIFEROL'? | Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis - Case report.
Hypercalcaemia is most commonly a sign of primary hyperparathyroidism but can also be a sign of an active granulomatous disease. Standard treatment for primary hyperparathyroidism caused by a solitary parat... | 1000 INTERNATIONAL UNIT | DrugDosageText | CC BY | 34336200 | 19,937,509 | 2021-08 |
What was the outcome of reaction 'Blood parathyroid hormone increased'? | Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis - Case report.
Hypercalcaemia is most commonly a sign of primary hyperparathyroidism but can also be a sign of an active granulomatous disease. Standard treatment for primary hyperparathyroidism caused by a solitary parat... | Recovered | ReactionOutcome | CC BY | 34336200 | 19,937,509 | 2021-08 |
What was the outcome of reaction 'Hypercalcaemia'? | Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis - Case report.
Hypercalcaemia is most commonly a sign of primary hyperparathyroidism but can also be a sign of an active granulomatous disease. Standard treatment for primary hyperparathyroidism caused by a solitary parat... | Recovered | ReactionOutcome | CC BY | 34336200 | 19,937,509 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pleurisy'. | An unusual case of invasive pleuritis and miliary Mycoplasma pneumonia during check-point inhibitor therapy.
A growing body of evidence suggests that check-point inhibitors not only increase the overall risk of infections, but, due to an altered immune response, may also result in atypical manifestations. We report a c... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY | 34336218 | 19,831,406 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia mycoplasmal'. | An unusual case of invasive pleuritis and miliary Mycoplasma pneumonia during check-point inhibitor therapy.
A growing body of evidence suggests that check-point inhibitors not only increase the overall risk of infections, but, due to an altered immune response, may also result in atypical manifestations. We report a c... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY | 34336218 | 19,831,406 | 2021-09 |
What was the outcome of reaction 'Pleurisy'? | An unusual case of invasive pleuritis and miliary Mycoplasma pneumonia during check-point inhibitor therapy.
A growing body of evidence suggests that check-point inhibitors not only increase the overall risk of infections, but, due to an altered immune response, may also result in atypical manifestations. We report a c... | Recovered | ReactionOutcome | CC BY | 34336218 | 19,831,406 | 2021-09 |
What was the outcome of reaction 'Pneumonia mycoplasmal'? | An unusual case of invasive pleuritis and miliary Mycoplasma pneumonia during check-point inhibitor therapy.
A growing body of evidence suggests that check-point inhibitors not only increase the overall risk of infections, but, due to an altered immune response, may also result in atypical manifestations. We report a c... | Recovered | ReactionOutcome | CC BY | 34336218 | 19,831,406 | 2021-09 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.